Compare LGN & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LGN | LMAT |
|---|---|---|
| Founded | 1963 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.0B |
| IPO Year | 2025 | 2006 |
| Metric | LGN | LMAT |
|---|---|---|
| Price | $48.45 | $86.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 6 |
| Target Price | $43.43 | ★ $101.83 |
| AVG Volume (30 Days) | ★ 1.1M | 143.6K |
| Earning Date | 11-14-2025 | 02-26-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | N/A | ★ 27.40 |
| EPS | N/A | ★ 2.32 |
| Revenue | ★ $2,361,064,000.00 | $240,866,000.00 |
| Revenue This Year | $17.08 | $15.17 |
| Revenue Next Year | $32.52 | $9.07 |
| P/E Ratio | ★ N/A | $36.96 |
| Revenue Growth | ★ 46.19 | 13.07 |
| 52 Week Low | $26.96 | $71.42 |
| 52 Week High | $50.20 | $105.55 |
| Indicator | LGN | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 54.54 |
| Support Level | N/A | $84.34 |
| Resistance Level | N/A | $88.36 |
| Average True Range (ATR) | 0.00 | 2.71 |
| MACD | 0.00 | 0.42 |
| Stochastic Oscillator | 0.00 | 75.35 |
Legence Corp is a provider of engineering, installation and maintenance services for mission-critical systems in buildings. It focuses on high-growth sectors that have technically demanding buildings, including technology, life sciences, healthcare and education. The company specializes in designing, fabricating and installing complex HVAC, process piping and other mechanical, electrical and plumbing (MEP) systems for new facilities and upgrading HVAC, lighting and building controls in existing facilities to make them more energy efficient and sustainable.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.